These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35587815)

  • 1. Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis.
    Stefánsdóttir ÍH; Ivarsson T; Skarphedinsson G
    Nord J Psychiatry; 2023 Feb; 77(2):137-146. PubMed ID: 35587815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Development on Antidepressant and Placebo Response in Anxiety Disorders: A Bayesian Hierarchical Meta-Analytic Examination of Randomized Controlled Trials in Children, Adolescents, and Adults.
    Mills JA; Mendez E; Strawn JR
    J Child Adolesc Psychopharmacol; 2024 Sep; 34(7):302-309. PubMed ID: 38800869
    [No Abstract]   [Full Text] [Related]  

  • 3. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
    Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
    Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrovascular, Cardiovascular, and Mortality Events in New Users of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: A Propensity Score-Matched Population-Based Study.
    Leong C; Alessi-Severini S; Enns MW; Nie Y; Sareen J; Bolton J; Prior HJ; Chateau D
    J Clin Psychopharmacol; 2017 Jun; 37(3):332-340. PubMed ID: 28383363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.
    Strawn JR; Mills JA; Sauley BA; Welge JA
    J Am Acad Child Adolesc Psychiatry; 2018 Apr; 57(4):235-244.e2. PubMed ID: 29588049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Pharmacotherapy for Pediatric Anxiety Disorders.
    Nicotra CM; Strawn JR
    Child Adolesc Psychiatr Clin N Am; 2023 Jul; 32(3):573-587. PubMed ID: 37201968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.
    Locher C; Koechlin H; Zion SR; Werner C; Pine DS; Kirsch I; Kessler RC; Kossowsky J
    JAMA Psychiatry; 2017 Oct; 74(10):1011-1020. PubMed ID: 28854296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents.
    Strawn JR; Mills JA; Poweleit EA; Ramsey LB; Croarkin PE
    Pharmacotherapy; 2023 Jul; 43(7):675-690. PubMed ID: 36651686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.
    Strawn JR; Welge JA; Wehry AM; Keeshin B; Rynn MA
    Depress Anxiety; 2015 Mar; 32(3):149-57. PubMed ID: 25449861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant Tolerability in Pediatric Anxiety and Obsessive-Compulsive Disorders: A Bayesian Hierarchical Modeling Meta-analysis.
    Mills JA; Strawn JR
    J Am Acad Child Adolesc Psychiatry; 2020 Nov; 59(11):1240-1251. PubMed ID: 31682918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines.
    Mendez EM; Mills JA; Suresh V; Stimpfl JN; Strawn JR
    CNS Spectr; 2024 Jun; 29(3):187-196. PubMed ID: 38523533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
    Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
    PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis.
    Gosmann NP; Costa MA; Jaeger MB; Frozi J; Spanemberg L; Manfro GG; Cortese S; Cuijpers P; Pine DS; Salum GA
    Psychol Med; 2023 Jul; 53(9):3783-3792. PubMed ID: 37278215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events.
    Lee YC; Lin CH; Lin MS; Lu Y; Chang CH; Lin JW
    J Clin Psychiatry; 2016 Jan; 77(1):e1-7. PubMed ID: 26845272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders.
    Walter HJ; Bukstein OG; Abright AR; Keable H; Ramtekkar U; Ripperger-Suhler J; Rockhill C
    J Am Acad Child Adolesc Psychiatry; 2020 Oct; 59(10):1107-1124. PubMed ID: 32439401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients.
    Smith MM; Smith BB; Lahr BD; Nuttall GA; Mauermann WJ; Weister TJ; Dearani JA; Barbara DW
    Anesth Analg; 2018 Jun; 126(6):1859-1866. PubMed ID: 29210786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.